109 related articles for article (PubMed ID: 8901021)
1. A glucocorticoid receptor-independent mechanism for neurosteroid inhibition of tumor necrosis factor production.
Di Santo E; Sironi M; Mennini T; Zinetti M; Savoldi G; Di Lorenzo D; Ghezzi P
Eur J Pharmacol; 1996 Mar; 299(1-3):179-86. PubMed ID: 8901021
[TBL] [Abstract][Full Text] [Related]
2. Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice.
Reddy DS; Kulkarni SK
Eur J Pharmacol; 1998 Mar; 345(1):55-9. PubMed ID: 9593594
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways.
Chen A; Vaughan J; Vale WW
Mol Endocrinol; 2003 Aug; 17(8):1622-39. PubMed ID: 12764078
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid- and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids.
Tanaka J; Fujita H; Matsuda S; Toku K; Sakanaka M; Maeda N
Glia; 1997 May; 20(1):23-37. PubMed ID: 9145302
[TBL] [Abstract][Full Text] [Related]
5. Blocking effect of anti-mouse interleukin-6 monoclonal antibody and glucocorticoid receptor antagonist, RU38486, on metallothionein-inducing activity of serum from lipopolysaccharide-treated mice.
Itoh N; Kasutani K; Muto N; Otaki N; Kimura M; Tanaka K
Toxicology; 1996 Aug; 112(1):29-36. PubMed ID: 8792846
[TBL] [Abstract][Full Text] [Related]
6. Neurosteroid levels are increased in vivo after LPS treatment and negatively regulate LPS-induced TNF production.
Ghezzi P; Santo ED; Sacco S; Foddi C; Barbaccia ML; Mennini T
Eur Cytokine Netw; 2000 Sep; 11(3):464-9. PubMed ID: 11022133
[TBL] [Abstract][Full Text] [Related]
7. DHEAS inhibits TNF production in monocytes, astrocytes and microglial cells.
Di Santo E; Foddi MC; Ricciardi-Castagnoli P; Mennini T; Ghezzi P
Neuroimmunomodulation; 1996; 3(5):285-8. PubMed ID: 9218249
[TBL] [Abstract][Full Text] [Related]
8. The neurosteroids dehydroepiandrosterone sulfate and pregnenolone sulfate inhibit the UNC-49 GABA receptor through a common set of residues.
Twede V; Tartaglia AL; Covey DF; Bamber BA
Mol Pharmacol; 2007 Nov; 72(5):1322-9. PubMed ID: 17715402
[TBL] [Abstract][Full Text] [Related]
9. Ciliary neurotrophic factor inhibits brain and peripheral tumor necrosis factor production and, when coadministered with its soluble receptor, protects mice from lipopolysaccharide toxicity.
Benigni F; Villa P; Demitri MT; Sacco S; Sipe JD; Lagunowich L; Panayotatos N; Ghezzi P
Mol Med; 1995 Jul; 1(5):568-75. PubMed ID: 8529123
[TBL] [Abstract][Full Text] [Related]
10. The Sulfated Steroids Pregnenolone Sulfate and Dehydroepiandrosterone Sulfate Inhibit the
Pierce SR; Germann AL; Steinbach JH; Akk G
Mol Pharmacol; 2022 Feb; 101(2):68-77. PubMed ID: 34853153
[TBL] [Abstract][Full Text] [Related]
11. Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram.
Pettipher ER; Labasi JM; Salter ED; Stam EJ; Cheng JB; Griffiths RJ
Br J Pharmacol; 1996 Apr; 117(7):1530-4. PubMed ID: 8730750
[TBL] [Abstract][Full Text] [Related]
12. Influence of neurosteroids on the development of rapid tolerance to ethanol in mice.
Barbosa AD; Morato GS
Eur J Pharmacol; 2001 Nov; 431(2):179-88. PubMed ID: 11728424
[TBL] [Abstract][Full Text] [Related]
13. Fenfluramine-induced immunosuppression: an in vivo analysis.
Connor TJ; Kelly JP
Eur J Pharmacol; 2002 Nov; 455(2-3):175-85. PubMed ID: 12445584
[TBL] [Abstract][Full Text] [Related]
14. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor.
Brouckaert P; Everaerdt B; Fiers W
Eur J Immunol; 1992 Apr; 22(4):981-6. PubMed ID: 1532365
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro.
Pickering WP; Baker FE; Brown J; Butler HL; Govindji S; Parsons JM; Pawluczyk IZ; Walls J; Bevington A
Nephrol Dial Transplant; 2003 Aug; 18(8):1475-84. PubMed ID: 12897084
[TBL] [Abstract][Full Text] [Related]
16. Protection against hypoxic-ischemic damage with corticosterone and dexamethasone: inhibition of effect by a glucocorticoid antagonist RU38486.
Tuor UI; Del Bigio MR
Brain Res; 1996 Dec; 743(1-2):258-62. PubMed ID: 9017253
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1 beta production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis.
Di Santo E; Sironi M; Pozzi P; Gnocchi P; Isetta AM; Delvaux A; Goldman M; Marchant A; Ghezzi P
Neuroimmunomodulation; 1995; 2(3):149-54. PubMed ID: 8646564
[TBL] [Abstract][Full Text] [Related]
18. Neurosteroid analogues. 6. The synthesis and GABAA receptor pharmacology of enantiomers of dehydroepiandrosterone sulfate, pregnenolone sulfate, and (3alpha,5beta)-3-hydroxypregnan-20-one sulfate.
Nilsson KR; Zorumski CF; Covey DF
J Med Chem; 1998 Jul; 41(14):2604-13. PubMed ID: 9651164
[TBL] [Abstract][Full Text] [Related]
19. DHEA, PREG and their sulphate derivatives on plasma and brain after CRH and ACTH administration.
Torres JM; Ortega E
Neurochem Res; 2003 Aug; 28(8):1187-91. PubMed ID: 12834258
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier.
Boivin MA; Ye D; Kennedy JC; Al-Sadi R; Shepela C; Ma TY
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G590-8. PubMed ID: 17068119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
